Education
Doctor of Philosophy, Kyoto University, Japan, 1990.
director pharmaceutical executive
Doctor of Philosophy, Kyoto University, Japan, 1990.
General manager, technical representative United States Republican Office Eisai Company Ltd, Teaneck, New Jersey, 1991—1993, director Tokyo, since 2001. Executive vice president Eisai Research Institute Boston, Andover, Massachusetts, 1994—1998. General manager, chief science officer KAN Research Laboratory, Kyoto, 1999—2000.
Licensed pharmacist Ministry Health, Labour and Welfare, Japan, 1977. Achievements include research in a new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human. Research in inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: evaluation of E5324, an ACAT inhibitor.
Member of New York Academy of Sciences (associate).
Children: Atsuko, Ryosuke.